Terms: = Leukemia AND MALT1, ENSG00000172175, 10892 AND Prognosis
4 results:
1. Novel identification of t(14;18)(q32;q21)/IGH::malt1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
2. Profiling the activity of the para-caspase malt1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Safa FM; Rasmussen T; Fontan L; Xia M; Melnick A; Wiestner A; Lobelle-Rich P; Burger JA; Mouawad Y; Safah H; Flemington EK; Saba NS
Haematologica; 2024 May; 109(5):1348-1358. PubMed ID: 37767562
[TBL] [Abstract] [Full Text] [Related]
3. Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-B Signaling.
Sato T; Maeta T; Ito S
Anticancer Res; 2023 May; 43(5):1901-1908. PubMed ID: 37097671
[TBL] [Abstract] [Full Text] [Related]
4. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]